G³-Next-Generation Triple-Agonist Peptide
Next-Generation Triple-Agonist Peptide
An investigational synthetic peptide developed for scientific examination of multi-receptor signaling, metabolic regulation, and systemic energy balance across GIP, GLP-1, and glucagon receptor pathways.
Product Specifications
Classification
Investigational, single-molecule triple-hormone receptor agonist (GIP, GLP-1, and glucagon receptor co-agonist).
Molecular Structure
Lipidated 39-amino-acid synthetic peptide sequence engineered with specialized stabilizing residues.
Research Focus
In-vitro and in-vivo evaluation of metabolic regulation, systemic energy balance, and multi-receptor signaling pathways.
Clinical Stage
The reference investigational compound has undergone Phase III clinical evaluation. Current trial status should be verified against official clinical trial records. This does not establish clinical authorization for the research material described here.
Key Research Characteristics
01 Multi-Receptor Engagement
Simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors to investigate synergistic metabolic responses.
02 Metabolic & Glycemic Profiling
Designed for scientific exploration of glucose homeostasis, lipid metabolism, and energy expenditure modulation.
03 Regulatory Status
Intended strictly for laboratory, biochemical, and authorized nonclinical research applications.
This research material is not approved for human or veterinary therapeutic use.
Handling, Storage & Stability
Laboratory Use & Compliance Agreement
Research Use Only Disclaimer
This product is intended strictly for in-vitro laboratory research, biochemical testing, and authorized laboratory animal experimentation. It is not intended for human or veterinary consumption, clinical diagnostics, or therapeutic applications.
Terms of Purchase
By purchasing or utilizing this material, the buyer acknowledges and agrees that:
- The product will be handled exclusively by qualified laboratory personnel trained in the safe handling of investigational peptides.
- The buyer is responsible for appropriate handling, storage, experimental procedures, and compliance with applicable laws and institutional safety requirements.
- This product is not an approved drug, food product, or medical device and must not be administered to human subjects.
- All research activities must comply with applicable institutional, ethical, and regulatory requirements.
- Product stability, purity, identity, and expiration claims must be supported by appropriate analytical documentation and
product-specific testing.
What our customers say
Independent customer feedback from Trustpilot





